NALO FORD: Open Payments
NPI 1780265181 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,787 in 44 payments from 15 companies in 2025. Trend: 2023 $1,915 · 2024 $1,812 · 2025 $1,787
Food & beverage: $1,787
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $429 |
| Sage Therapeutics, LLC | 2 | $198 |
| ABBVIE INC. | 8 | $196 |
| Axsome Therapeutics, Inc. | 4 | $182 |
| Novo Nordisk Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 5 | $111 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| COLOPLAST CORP | 1 | $76 |
Products named: COBENFY, VRAYLAR, Auvelity, Wegovy, HETLIOZ, CAPLYTA, Titan, REXULTI.
Industry payments across MD — which companies pay providers there.
